Face-to-Face Pharma Forecasting Training

October 16-17, 2019 | USA

A face-to-face pharmaceutical forecasting training course that advances your forecasting knowledge and capability. Learning alongside like-minded individuals from other organisations for 2 days at a central location.

Spotlight

For those who have no idea what CRISPR is all about, the abbreviation means “Clustered Regularly Interspaced Short Palindromic Repeats.” It’s a family of DNA sequences in bacteria. The sequences here play a huge role in fighting bacteria within the body, and if improved, could fight dangerous illnesses as well. This technology for gene-editing treatment has been in the works for quite some time, but could finally come to market due to a company was known as CRISPR Therapeutics.


OTHER PAST CONFERENCES

Drug Discovery and Drug Development

November 24-25, 2022 | USA

Allied Academies every year hosts interdisciplinary international conferences worldwide oncutting-edge basic and applied research in life sciences, Pharma,Medicine, Healthcareand Nursing deliveredby the best talents in industry and academia.

Pharma Industry & pharmaceuticals

October 3-4, 2022 | France

After a decent assembling of past drug organization gatherings, drug Conferences group merrily invites individuals from everyplace the planet to venture out to " third International meeting on Pharma Industry and drugs"

AAPS 2022 PHARMSCI 360

October 16-19, 2022 | USA

AAPS 2022 PHARMSCI 360 October 16-19, 2022 Boston Convention & Exhibition Center Boston, MA

The worlds largest commercial pharma event

October 11-13, 2022 | France

We’ve entered a new era. One where being risk averse is the riskiest strategy, long-established operating models have been torn up and reimagined,

Spotlight

For those who have no idea what CRISPR is all about, the abbreviation means “Clustered Regularly Interspaced Short Palindromic Repeats.” It’s a family of DNA sequences in bacteria. The sequences here play a huge role in fighting bacteria within the body, and if improved, could fight dangerous illnesses as well. This technology for gene-editing treatment has been in the works for quite some time, but could finally come to market due to a company was known as CRISPR Therapeutics.

resources